BK-1361

Research use only, not for human use.

BK-1361(BK1361, cyclo-RLsKDK) is a cyclic peptide with RLsKDK (s=D-serine) that functions as a potent, selective inhibitor of ADAM8 with IC50 of 120 nM.

BK-1361(BK1361, cyclo-RLsKDK) is a cyclic peptide with RLsKDK (s=D-serine) that functions as a potent, selective inhibitor of ADAM8 with IC50 of 120 nM; displays no significant activity against ADAM 9, 10, 12, 17 , as well as MMP-2, -9, and -14 at 10 uM; inhibit shedding of CD23 with IC50 of 182 nM in cell-based shedding assays, reduces migration/invasion of pancreatic cancer cells and less ERK1/2 and MMP activation, causes change in cell morphology; decreases tumour burden and metastasis of implanted pancreatic tumour cells and provides improved metrics of clinical symptoms and survival in Kras(G12D)-driven mouse model of PDAC.

Cell Invasion Assay Cell Line:Panc1_A8 cells.Concentration:10, 100 and 1,000?nM.Incubation Time:6?h.Result:Reduced cell invasion with dose-dependent manner.

——

BK 1361 | BK1361 | cyclo-RLsKDK

Others

Other Targets

——

——

——

1975145-82-4

727.86

C31H57N11O9

>98% (HPLC)

——

——

——

(-20℃)

With Ice Pack

≥ 2 years